Drug intelligence / Profile preview

Cordia verbenacea essential oil

Development stage
Unknown
Lead developer
Ache Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Acheflan is a topical anti-inflammatory phytomedicine developed and marketed by Aché Laboratórios Farmacêuticos S.A. in Brazil. It is derived from the essential oil of *Cordia verbenacea* DC, a plant native to the Brazilian Atlantic Forest. The product is standardized to alpha-humulene, which serves as the primary active marker. Its mechanism of action involves the inhibition of pro-inflammatory mediators, specifically reducing the production of tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), as well as decreasing the expression of cyclooxygenase-2 (COX-2). Acheflan is indicated for the local treatment of inflammatory conditions such as tendinitis, muscle pain, lower back pain, and injuries resulting from trauma, such as sprains and contusions. It was the first pharmaceutical product entirely researched and developed in Brazil, resulting from a seven-year collaboration between Aché and national universities.

Brand names
Acheflan
Other names
Cordia verbenacea extractalpha-humulene
02

Targets

IL-6 (Interleukin 6)NOS2 (Nitric Oxide Synthase 2)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Cordia verbenacea essential oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cordia verbenacea essential oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call